LAPIX Therapeutics Inc. Announces a Successful Conclusion of its Pre-IND Meeting…
BOSTON, Jan. 26, 2023 (GLOBE NEWSWIRE) -- LAPIX Therapeutics, Inc. (“LAPIX”), a biopharma company focused on developing novel, orally bioavailable immune system restoration therapies for…